118 related articles for article (PubMed ID: 10525606)
1. [Prognostic significance of cell-cycle regulatory proteins for outcome after primary radiochemotherapy in patients with advanced head and neck cancer].
Haas S; Bosch FX; Klein-Kühne W; Nollert J; Rudat V; Conradt C; Dietz A
HNO; 1999 Sep; 47(9):777-86. PubMed ID: 10525606
[TBL] [Abstract][Full Text] [Related]
2. [Immunohistochemical determination of cell cycle regulatory proteins. No prognostic significance in advanced squamous epithelial carcinomas of the head-neck area].
Kunz C; Bosch FX; Klein-Kühne W; Nollert J; Rudat V; Conradt C; Dietz A
HNO; 2003 Oct; 51(10):800-5. PubMed ID: 14523533
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy.
Rudat V; Dietz A; Schramm O; Conradt C; Maier H; Flentje M; Wannenmacher M
Radiother Oncol; 1999 Nov; 53(2):119-25. PubMed ID: 10665788
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck.
Michalides RJ; van Veelen NM; Kristel PM; Hart AA; Loftus BM; Hilgers FJ; Balm AJ
Arch Otolaryngol Head Neck Surg; 1997 May; 123(5):497-502. PubMed ID: 9158396
[TBL] [Abstract][Full Text] [Related]
5. MASPIN's prognostic role in patients with advanced head and neck carcinoma treated with primary chemotherapy (carboplatin plus vinorelbine) and radiotherapy: preliminary evidence.
Marioni G; Koussis H; Gaio E; Giacomelli L; Bertolin A; D'Alessandro E; Scola A; Ottaviano G; de Filippis C; Jirillo A; Staffieri A; Blandamura S
Acta Otolaryngol; 2009 Jul; 129(7):786-92. PubMed ID: 18819022
[TBL] [Abstract][Full Text] [Related]
6. [Polarographic detection of reoxygenation of lymph node metastases in the initial phase of primary radio- and radiochemotherapy in patients with advanced squamous epithelial carcinomas of the head and neck].
Vanselow B; Dietz A; Rudat V; Wollensack P; Bettscheider C; Eble MJ
HNO; 1997 Mar; 45(3):140-6. PubMed ID: 9417437
[TBL] [Abstract][Full Text] [Related]
7. [Frequency and distribution pattern of distant metastases in patients with ENT tumors and their consequences for pretherapeutic staging].
Dietl B; Marienhagen J; Schaefer C; Pohl F; Kölbl O
Strahlenther Onkol; 2007 Mar; 183(3):138-43. PubMed ID: 17340072
[TBL] [Abstract][Full Text] [Related]
8. High-grade acute organ toxicity and p16(INK4A) expression as positive prognostic factors in primary radio(chemo)therapy for patients with head and neck squamous cell carcinoma.
Tehrany N; Kitz J; Rave-Fränk M; Lorenzen S; Li L; Küffer S; Hess CF; Burfeind P; Reichardt HM; Canis M; Beissbarth T; Wolff HA
Strahlenther Onkol; 2015 Jul; 191(7):566-72. PubMed ID: 25575976
[TBL] [Abstract][Full Text] [Related]
9. [Effect of primary radiochemotherapy on cellular and subcellular immunologic parameters].
Nollert J; Rudat V; Daniel V; Maier H; Dietz A
HNO; 1999 Dec; 47(12):1058-62. PubMed ID: 10654183
[TBL] [Abstract][Full Text] [Related]
10. [Accelerated hyperfractionated simultaneous radiochemotherapy in advanced head-neck carcinomas in comparison: split course and concomitant boost concept].
Dietz A; Rudat V; Nollert J; Flentje M; Maiei H; Wannenmacher M; Weidauer H
Laryngorhinootologie; 1996 Dec; 75(12):745-53. PubMed ID: 9081280
[TBL] [Abstract][Full Text] [Related]
11. Induction chemotherapy by superselective intra-arterial high-dose carboplatin infusion for head and neck cancer.
Benazzo M; Caracciolo G; Zappoli F; Bernardo G; Mira E
Eur Arch Otorhinolaryngol; 2000; 257(5):279-82. PubMed ID: 10923944
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic significance of immunohistochemical studies].
Montenarh M
HNO; 2003 Oct; 51(10):787-9. PubMed ID: 14523530
[No Abstract] [Full Text] [Related]
13. Predictive value of the flow cytometric PCNA assay (proliferating cell nuclear antigen) in head and neck tumors after accelerated-hyperfractionated radiochemotherapy.
Wenz F; Lohr F; Flentje M; Rudat V; Dietz A; Wannenmacher M
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):771-6. PubMed ID: 9128950
[TBL] [Abstract][Full Text] [Related]
14. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic factors in head-neck carcinomas].
Weber A; Tannapfel A
HNO; 2002 Jan; 50(1):35-42. PubMed ID: 11963785
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic factors in primary radiochemo-therapy in advanced head and neck tumours with specific reference to the tumour cell cycle components and tumour oxygenation].
Dietz A
Laryngorhinootologie; 2002 Jan; 81(1):63-4. PubMed ID: 11845405
[No Abstract] [Full Text] [Related]
17. Treatment results and prognostic factors for advanced squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
Taguchi T; Tsukuda M; Mikami Y; Matsuda H; Tanigaki Y; Horiuchi C; Nishimura G; Nagao J
Auris Nasus Larynx; 2009 Apr; 36(2):199-204. PubMed ID: 18632233
[TBL] [Abstract][Full Text] [Related]
18. [Concomitant radiochemotherapy in locally advanced ORL cancers: a prospective study of 68 cases].
Maylin C; Walter S; Hennequin C; Brette MD; Durdux C; Monteil JP; Deboise A
Bull Cancer Radiother; 1996; 83(2):108-10. PubMed ID: 8688216
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant radiochemotherapy and radical resection for advanced squamous cell carcinoma of the oral cavity. Outcome of 134 patients.
Eich HT; Löschcke M; Scheer M; Kocher M; Bongartz R; Wacker S; Zöller JE; Müller RP
Strahlenther Onkol; 2008 Jan; 184(1):23-9. PubMed ID: 18188519
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in squamous cell carcinoma of the head and neck.
Wendt TG; Bank P
Onkologie; 2002 Jun; 25(3):208-12. PubMed ID: 12119454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
